spironolactone
- Product NDC
- 31722-691
- 11-digit product format
- 317220691
- Labeler code
- 31722
- Product ID
- 31722-691_3241a29b-82b9-fd3a-e063-6294a90aa46c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- spironolactone
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Camber Pharmaceuticals, Inc.
- Application
- ANDA218085
- Marketing category
- ANDA
- Marketing start
- 2025-02-21
- Substance
- SPIRONOLACTONE
- Active strength
- 25 mg/5mL
- Pharmacologic classes
- Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- spironolactone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SPIRONOLACTONE | 25 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 27O7W4T232 |
| Rxcui | 104232 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 31722-691-11 | spironolactone | 118 mL in 1 BOTTLE | SUSPENSION | 118 | | 1 |
| 31722-691-47 | spironolactone | 473 mL in 1 BOTTLE | SUSPENSION | 473 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 31722-691 | SPIRONOLACTONE (SPIRONOLACTONE) SUSPENSION [CAMBER PHARMACEUTICALS, INC.] | 1 | Current NDC, 2 package rows | 20250410_4ac2926a-949a-4383-b0b0-92c0822dfcda.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 31722-691-11 | 31722069111 | 118 mL in 1 BOTTLE (31722-691-11) | 118 ml | 2025-02-21 | No | No | Current |
| 31722-691-47 | 31722069147 | 473 mL in 1 BOTTLE (31722-691-47) | 473 ml | 2025-02-21 | No | No | Current |